Structural basis for resistance to diverse classes of NAMPT inhibitors
about
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncologyExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokineIdentification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells.Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment.
P2860
Structural basis for resistance to diverse classes of NAMPT inhibitors
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Structural basis for resistance to diverse classes of NAMPT inhibitors
@ast
Structural basis for resistance to diverse classes of NAMPT inhibitors
@en
Structural basis for resistance to diverse classes of NAMPT inhibitors
@nl
type
label
Structural basis for resistance to diverse classes of NAMPT inhibitors
@ast
Structural basis for resistance to diverse classes of NAMPT inhibitors
@en
Structural basis for resistance to diverse classes of NAMPT inhibitors
@nl
prefLabel
Structural basis for resistance to diverse classes of NAMPT inhibitors
@ast
Structural basis for resistance to diverse classes of NAMPT inhibitors
@en
Structural basis for resistance to diverse classes of NAMPT inhibitors
@nl
P2093
P2860
P3181
P1433
P1476
Structural basis for resistance to diverse classes of NAMPT inhibitors
@en
P2093
Bobby Brillantes
Deepak Sampath
Eric Cheng
Jiansheng Wu
Kenneth W Bair
Kristi Elkins
Lisa Crocker
Lisa D Belmont
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0109366
P407
P577
2014-01-01T00:00:00Z